BANGALORE, July 29 (Reuters) - Discovery Laboratories Inc (DSCO.O) said it was actively assessing various strategic and financial alternatives to secure necessary capital, adding that it would curtail investments in its respiratory pipeline programs until it raised capital or got a partner.
